MEDISAN

Zhitong · Oct 29, 2025 at 02:52 AM

MEDISAN: The company's drugs, Rosuvastatin capsules and Chlorpromazine for injection, are expected to win the bid

Zhitong · Oct 21, 2025 at 08:41 PM

The innovative drug concept strengthened at the beginning of the trading session, with MEDISAN and ALK both hitting the daily limit

Zhitong · Sep 29, 2025 at 08:01 PM

Zhitong A-share lock-up release overview | September 30

Zhitong · Sep 17, 2025 at 05:27 AM

MEDISAN Pharmaceuticals: In the third phase of the 2022 incentive plan, 166 individuals can lift the sales restrictions

Zhitong · Aug 26, 2025 at 04:07 AM

MEDISAN released its performance for the first half of the year, turning from profit to a loss of 92.3904 million yuan

Wallstreetcn · Jul 23, 2025 at 08:32 PM

The A-share innovative drug concept continues to be strong, with YABAO PHARM.CORP hitting the limit up, and JENKEM, HSGC, YKYY, MEDISAN, HITECK, and others leading in gains